ABSTRACT

KEYWORDS

REFERENCES

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Document 2006. NHLB/WHO Global initiative for chronic lung Disease. www.goldcopd.org

2. Coleman T. Smoking cessation: integrating recent advances into clinical practice. Thorax 2001; 56: 579-582.

3. Consensus Statement. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA 1996; 16: 1270-1280.

4. Munafo M, Rigotti N, Lancaster T, Stead L, Murphy M. Interventions for smoking cessation in hospitalized patients: a systemic review. Thorax 2001; 56: 656-663.

5. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, et al. Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, versus placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006; 296: 56-63.

6. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, et al. Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006; 296: 64-71.

7. Sansores MRH, Cordoba PMP, Espinosa MM, Herrera KL, Ramírez VA, et al. Evaluación del programa cognitivo conductual para dejar de fumar en el Instituto Nacional de Enfermedades Respiratorias. Rev Inst Nal Enf Resp Méx 1998; 11: 29-35.

8. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1985; 102: 29-36.

9. Hanneke AC, van Hevoort, Heijdra FI, Heunks LMA, et al. Supplemental oxygen prevent exercise-induced oxidative stress in muscle-wasted patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 1122-1129.

10. Timms RM, Fareed UK, Williams GW, and the NOTT Group. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102: 29-36.

11. British Medical Research Council Working Party. Long-Term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-685.

12. Somafy A. Porszasz J, Lee SM, Casaburi R. Rose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxemic COPD patients. Eur Respir J 2001; 18: 77-84.

13. Gong H Jr. Air Travel and Oxygen Therapy in cardiopulmonary patients. Chest 1992; 101: 1104-1113.

14. Berg BW, Dillard TA, Rajagopal KR, Mehm WJ. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest 1992; 101: 638-641.

15. Gong H, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis 1984; 130: 980-986.

16. Christensen CC, Ryg MS, Refvem OK, Skjonsberg OH. Development of severe hypoxemia in chronic obstructive pulmonary disease. Patients at 2, 438 m (8,000 ft) altitude. Eur Respir J 2000; 15: 635-639.

17. Jones SE, Packham S, Hebden M, Smith AP. Domiciliary nocturnal intermitent positive presure ventilation in patient with respiratory failure due to severe COPD: Long term follow up and effect on survival. Thorax 1998; 53: 495-498.

18. Wijsktra PJ, Lacasse Y, Guyatt GH, Casanova C, Gay PC, Jones JM, et al. A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest 2003; 124: 337-34.

19. Diaz O, Begin P, Andresen M, Prieto ME, Castillo C, Jorquera J, et al. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J 2005; 26: 1016-1023.

20. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, et al. The italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538.

21. Nava S, Ambrosino N, Rubini F, Fracchia C, Rampulla C, et al. Effect of nasal pressure support ventilation and external PEEP on diaphragmatic activity in patients with severe stable COPD. Chest 1993; 103: 143-150.